Abstract：
Both patients and physicians may be hesitant toward vaccination in patients with asthma, which may result in lower vaccine uptake. The aim of this work was to investigate the vaccination rate, the adverse reactions, as well as the factors associated with vaccine acceptance and hesitancy toward COVID-19 vaccination among asthmatic patients in Beijing.
A multi-center, cross-sectional face-to-face survey was conducted in patients with asthma consecutively recruited from December 2021 to April 2022. The survey included asthma status, COVID-19 vaccine uptake and adverse reactions, and knowledge of and attitude toward COVID-19 vaccination.
A total of 261 patients were enrolled. The rate of COVID-19 vaccination during the study period was 73.6%, as compared to 87.64% in the general population in China. Patients who were currently working, had received other vaccines in the past, and had had no adverse reactions to other vaccines, showed a higher rate of COVID-19 vaccination. Patients believing that the vaccination of family members and colleagues had a positive impact on their decision to get vaccinated, were more likely to get the COVID-19 vaccines. The COVID-19 vaccination rate was lower in those with poorly monitored asthma and those using biologic therapies. The adverse effects of COVID-19 vaccines in asthmatic patients were similar to those in the general population.
The COVID-19 vaccination rate in asthmatic patients was lower than the general population in China. Active measures should be taken to control asthma and increase vaccination rates in these patients.
A multi-center, cross-sectional face-to-face survey was conducted in patients with asthma consecutively recruited from December 2021 to April 2022. The survey included asthma status, COVID-19 vaccine uptake and adverse reactions, and knowledge of and attitude toward COVID-19 vaccination.
A total of 261 patients were enrolled. The rate of COVID-19 vaccination during the study period was 73.6%, as compared to 87.64% in the general population in China. Patients who were currently working, had received other vaccines in the past, and had had no adverse reactions to other vaccines, showed a higher rate of COVID-19 vaccination. Patients believing that the vaccination of family members and colleagues had a positive impact on their decision to get vaccinated, were more likely to get the COVID-19 vaccines. The COVID-19 vaccination rate was lower in those with poorly monitored asthma and those using biologic therapies. The adverse effects of COVID-19 vaccines in asthmatic patients were similar to those in the general population.
The COVID-19 vaccination rate in asthmatic patients was lower than the general population in China. Active measures should be taken to control asthma and increase vaccination rates in these patients.
摘要：
目的：患者和医生都可能对哮喘患者的疫苗接种犹豫不决，这可能导致较低的疫苗摄取。这项工作的目的是调查疫苗接种率，不良反应,以及与疫苗接受相关的因素和北京哮喘患者对COVID-19疫苗接种的犹豫。方法：多中心，我们在2021年12月至2022年4月连续招募的哮喘患者中进行了横断面面对面调查.调查包括哮喘状况，COVID-19疫苗摄取和不良反应，以及对COVID-19疫苗接种的知识和态度。结果：共纳入261例患者。研究期间COVID-19疫苗接种率为73.6%，相比之下，中国总人口为87.64%。目前正在工作的患者，过去接种过其他疫苗，并且对其他疫苗没有不良反应，显示COVID-19疫苗接种率较高。患者认为家庭成员和同事的疫苗接种对他们接种疫苗的决定有积极影响，更有可能获得COVID-19疫苗。在哮喘监测不佳和使用生物疗法的人群中，COVID-19疫苗接种率较低。COVID-19疫苗对哮喘患者的不良反应与一般人群相似。结论:中国哮喘患者COVID-19疫苗接种率低于一般人群。应采取积极措施控制哮喘，提高这些患者的疫苗接种率。
